Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.

Kulkarni A, Pillai R, Ezekiel AM, Henner WD, Handorf CR.

Diagn Pathol. 2012 Aug 21;7:110. doi: 10.1186/1746-1596-7-110.

2.

A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.

Handorf CR, Kulkarni A, Grenert JP, Weiss LM, Rogers WM, Kim OS, Monzon FA, Halks-Miller M, Anderson GG, Walker MG, Pillai R, Henner WD.

Am J Surg Pathol. 2013 Jul;37(7):1067-75. doi: 10.1097/PAS.0b013e31828309c4.

3.

Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.

Greco FA, Lennington WJ, Spigel DR, Hainsworth JD.

J Natl Cancer Inst. 2013 Jun 5;105(11):782-90. doi: 10.1093/jnci/djt099. Epub 2013 May 2.

PMID:
23641043
4.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.

5.

[Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification].

Morawietz L, Floore A, Stork-Sloots L, Folprecht G, Buettner R, Rieger A, Dietel M, Huebner G.

Pathologe. 2009 Dec;30 Suppl 2:168-72. doi: 10.1007/s00292-009-1194-4. German.

PMID:
19756615
6.

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.

Hainsworth JD, Greco FA.

Virchows Arch. 2014 Apr;464(4):393-402. doi: 10.1007/s00428-014-1545-2. Epub 2014 Feb 1. Review.

PMID:
24487792
7.

A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.

Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Huang VJ, Erlander MG, Brachtel EF, Dry SM.

Mod Pathol. 2014 Jan;27(1):44-54. doi: 10.1038/modpathol.2013.105. Epub 2013 Jul 12.

8.

A gene expression profile test to resolve head & neck squamous versus lung squamous cancers.

Lal A, Panos R, Marjanovic M, Walker M, Fuentes E, Kubicek GJ, Henner WD, Buturovic LJ, Halks-Miller M.

Diagn Pathol. 2013 Mar 11;8:44. doi: 10.1186/1746-1596-8-44.

9.

Comparison of histopathological and gene expression-based typing of cancer of unknown primary.

Morawietz L, Floore A, Stork-Sloots L, Folprecht G, Buettner R, Rieger A, Dietel M, Huebner G.

Virchows Arch. 2010 Jan;456(1):23-9. doi: 10.1007/s00428-009-0867-y. Epub 2009 Dec 10.

PMID:
20012089
10.

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.

Am J Surg Pathol. 2012 Jul;36(7):945-54. doi: 10.1097/PAS.0b013e318253a2d1.

PMID:
22743284
11.

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, Leizerman I, Ashkenazi K, Spector Y, Chajut A, Aharonov R.

Mod Pathol. 2010 Jun;23(6):814-23. doi: 10.1038/modpathol.2010.57. Epub 2010 Mar 26.

12.

Gene expression profiles help identify the tissue of origin for metastatic brain cancers.

Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R.

Diagn Pathol. 2010 Apr 26;5:26. doi: 10.1186/1746-1596-5-26.

13.

Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin.

Azueta A, Maiques O, Velasco A, Santacana M, Pallares J, Novell A, Llombart-Cussac A, Gonzalez-Tallada X, Mozos A, Prat J, Pillai R, Mata M, Matias-Guiu X.

Hum Pathol. 2013 Jan;44(1):20-8. doi: 10.1016/j.humpath.2012.04.018. Epub 2012 Aug 30.

PMID:
22939961
14.

Rapid detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors.

Truong LN, Patil S, Martin SS, LeBlanc JF, Nanda A, Nordberg ML, Beckner ME.

Diagn Pathol. 2012 Jun 12;7:66. doi: 10.1186/1746-1596-7-66.

15.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D.

J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.

PMID:
18802156
16.

Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.

Belloni B, Lambertini C, Nuciforo P, Phillips J, Bruening E, Wong S, Dummer R.

J Clin Pathol. 2013 Feb;66(2):124-35. doi: 10.1136/jclinpath-2012-200983. Epub 2012 Nov 3.

17.

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material.

Gravendeel LA, de Rooi JJ, Eilers PH, van den Bent MJ, Sillevis Smitt PA, French PJ.

Br J Cancer. 2012 Jan 31;106(3):538-45. doi: 10.1038/bjc.2011.547. Epub 2011 Dec 20.

18.

Comparison of formalin-free tissue fixatives: a proteomic study testing their application for routine pathology and research.

Kothmaier H, Rohrer D, Stacher E, Quehenberger F, Becker KF, Popper HH.

Arch Pathol Lab Med. 2011 Jun;135(6):744-52. doi: 10.1043/2009-0676-OA.1.

PMID:
21631267
19.

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN.

Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599. Epub 2011 Apr 29.

20.

Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.

Ross JS, Wang K, Rand JV, Sheehan CE, Jennings TA, Al-Rohil RN, Otto GA, Curran JC, Palmer G, Downing SR, Yelensky R, Lipson D, Balasubramanian S, Garcia L, Mahoney K, Ali SM, Miller VA, Stephens PJ.

Am J Surg Pathol. 2014 Feb;38(2):235-8. doi: 10.1097/PAS.0000000000000102.

PMID:
24418857

Supplemental Content

Support Center